+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Type 2 Diabetes Drug"

Type 2 Diabetes Drugs Market by Drug, Application, Distribution - Global Forecast 2025-2030 - Product Thumbnail Image

Type 2 Diabetes Drugs Market by Drug, Application, Distribution - Global Forecast 2025-2030

  • Report
  • October 2024
  • 181 Pages
  • Global
From
Diabetic nephropathy Market by Diabetes Type, Drug Class, End-Use, Route of Administration - Global Forecast 2025-2030 - Product Thumbnail Image

Diabetic nephropathy Market by Diabetes Type, Drug Class, End-Use, Route of Administration - Global Forecast 2025-2030

  • Report
  • October 2024
  • 192 Pages
  • Global
From
Diabetes Drugs - Global Strategic Business Report - Product Thumbnail Image

Diabetes Drugs - Global Strategic Business Report

  • Report
  • March 2025
  • 196 Pages
  • Global
From
Empagliflozin, Dapagliflozin and Canagliflozin Market Report 2024 - Product Thumbnail Image

Empagliflozin, Dapagliflozin and Canagliflozin Market Report 2024

  • Report
  • September 2024
  • 175 Pages
  • Global
From
Type 2 Diabetes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Type 2 Diabetes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 140 Pages
  • Global
From
Type 2 Diabetes - Pipeline Insight, 2024 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Insight, 2024

  • Drug Pipelines
  • November 2024
  • 240 Pages
  • Global
From
Type 2 Diabetes - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Type 2 Diabetes - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Type 2 Diabetes Pipeline Analysis Report - Product Thumbnail Image

Type 2 Diabetes Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
Human Insulin Market Size and Forecasts 2020-2031: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product Type, Application, and End-user - Product Thumbnail Image

Human Insulin Market Size and Forecasts 2020-2031: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product Type, Application, and End-user

  • Report
  • September 2024
  • 117 Pages
  • Global
From
Type 2 Diabetes Treatment: Global Market Outlook - Product Thumbnail Image

Type 2 Diabetes Treatment: Global Market Outlook

  • Report
  • December 2022
  • 66 Pages
  • Global
From
Global Markets for Diabetes Therapeutics and Diagnostics - Product Thumbnail Image

Global Markets for Diabetes Therapeutics and Diagnostics

  • Report
  • August 2023
  • 336 Pages
  • Global
From
Diabetes Drugs Market, Size, Global Forecast 2023-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis - Product Thumbnail Image

Diabetes Drugs Market, Size, Global Forecast 2023-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis

  • Report
  • July 2023
  • 220 Pages
  • Global
From
Saudi Arabia Diabetes Drug & Insulin Delivery Device Market Opportunity Outlook 2025 - Product Thumbnail Image

Saudi Arabia Diabetes Drug & Insulin Delivery Device Market Opportunity Outlook 2025

  • Report
  • August 2020
  • 250 Pages
  • Saudi Arabia
From
Japan Diabetes Drugs and Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029 - Product Thumbnail Image

Japan Diabetes Drugs and Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

  • Report
  • February 2024
  • 70 Pages
  • Japan
From
Cushing's Syndrome Diagnostic And Treatment Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Cushing's Syndrome Diagnostic And Treatment Market - Forecasts from 2022 to 2027

  • Report
  • March 2022
  • 124 Pages
  • Global
From
Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2029 - Product Thumbnail Image

Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2029

  • Report
  • October 2020
  • 133 Pages
  • Global
From
Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • February 2022
  • 62 Pages
  • Global
From
Type 2 Diabetes in the United States: Key Insights into Treatment Awareness & Satisfaction - Product Thumbnail Image

Type 2 Diabetes in the United States: Key Insights into Treatment Awareness & Satisfaction

  • Report
  • January 2024
  • 120 Pages
  • United States
Hyperglycemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hyperglycemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 35 Pages
  • Global
From
Type 2 Diabetes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Type 2 Diabetes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 1127 Pages
  • Global
From
Loading Indicator

The Type 2 Diabetes Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. These drugs are used to treat Type 2 Diabetes, a chronic condition in which the body does not produce enough insulin or is unable to use insulin properly. Type 2 Diabetes Drugs are used to help control blood sugar levels, reduce the risk of complications, and improve overall health. These drugs can be taken orally, injected, or inhaled. Common Type 2 Diabetes Drugs include Metformin, Sulfonylureas, Thiazolidinediones, Meglitinides, DPP-4 Inhibitors, GLP-1 Receptor Agonists, and SGLT2 Inhibitors. Some companies in the Type 2 Diabetes Drug market include Novo Nordisk, Sanofi, Eli Lilly, Merck, AstraZeneca, Boehringer Ingelheim, and Takeda. Show Less Read more